We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-6.97%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$10.4B
AUM Growth
-$1.52B
Cap. Flow
-$723M
Cap. Flow %
-6.93%
Top 10 Hldgs %
32.83%
Holding
1,239
New
73
Increased
466
Reduced
278
Closed
97

Top Buys

Rank Stock Value
1
SITC icon
SITE Centers
SITC
+$150M
2
AMT icon
American Tower
AMT
+$128M
3
IRM icon
Iron Mountain
IRM
+$127M
4
SBAC icon
SBA Communications
SBAC
+$124M
5
PSA icon
Public Storage
PSA
+$113M

Top Sells

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$211M
2
SPG icon
Simon Property Group
SPG
+$184M
3
HR icon
Healthcare Realty
HR
+$174M
4
DLR icon
Digital Realty Trust
DLR
+$163M
5
OHI icon
Omega Healthcare
OHI
+$160M

Sector Composition

Rank Sector Weight
1 Real Estate 74.77%
2 Technology 3.37%
3 Industrials 3.06%
4 Financials 2.76%
5 Healthcare 2.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GTHX
1076
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$3K ﹤0.01%
157
– –
CCXI
1077
DELISTED
ChemoCentryx, Inc.
CCXI
$3K ﹤0.01%
269
– –
AMAG
1078
DELISTED
AMAG Pharmaceuticals
AMAG
$3K ﹤0.01%
195
– –
ADAP
1079
DELISTED
Adaptimmune Therapeutics
ADAP
$2K ﹤0.01%
323
– –
CIEN icon
1080
PUT
Ciena
CIEN
$52B
$2K ﹤0.01%
2,032
– –
CRBP icon
1081
Corbus Pharmaceuticals
CRBP
$175M
$2K ﹤0.01%
10
– –
CYTK icon
1082
Cytokinetics
CYTK
$11B
$2K ﹤0.01%
298
– –
CBIO
1083
Crescent Biopharma
CBIO
$639M
$2K ﹤0.01%
2
– –
INO icon
1084
Inovio Pharmaceuticals
INO
$80.8M
$2K ﹤0.01%
42
– –
KPTI icon
1085
Karyopharm Therapeutics
KPTI
$172M
$2K ﹤0.01%
17
– –
KURA icon
1086
Kura Oncology
KURA
$936M
$2K ﹤0.01%
167
– –
ON icon
1087
PUT
ON Semiconductor
ON
$33.6B
$2K ﹤0.01%
2,000
– –
RIGL icon
1088
Rigel Pharmaceuticals
RIGL
$702M
$2K ﹤0.01%
81
– –
VCYT icon
1089
Veracyte
VCYT
$4.5B
$2K ﹤0.01%
188
– –
VYGR icon
1090
Voyager Therapeutics
VYGR
$187M
$2K ﹤0.01%
178
– –
TVRD
1091
Tvardi Therapeutics
TVRD
$24.7M
$2K ﹤0.01%
5
– –
PETQ
1092
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$2K ﹤0.01%
73
– –
NSTG
1093
DELISTED
NanoString Technologies, Inc.
NSTG
$2K ﹤0.01%
140
– –
CNCE
1094
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$2K ﹤0.01%
126
– –
EPZM
1095
DELISTED
Epizyme, Inc
EPZM
$2K ﹤0.01%
383
– –
FLXN
1096
DELISTED
Flexion Therapeutics, Inc.
FLXN
$2K ﹤0.01%
207
– –
PGNX
1097
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$2K ﹤0.01%
388
– –
RARX
1098
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$2K ﹤0.01%
125
– –
PDLI
1099
DELISTED
PDL BioPharma, Inc.
PDLI
$2K ﹤0.01%
853
– –
ABUS icon
1100
Arbutus Biopharma
ABUS
$879M
$1K ﹤0.01%
304
– –
42 43
44
45 46

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q4 2018 Portfolio in Review

As of Q4 2018, Daiwa Securities Group held 1,239 positions worth $10.4B, down 13% from $11.9B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Daiwa Securities Group withdrew a net $723M in Q4 2018, closing 97 positions and reducing 278 holdings. Its most notable exit was Steris, an estimated $11.9M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 75% of assets, up from 72% a quarter earlier, followed by Technology and Industrials.

Against the trend, Daiwa Securities Group opened a new position in SITE Centers worth $138M.

  • Daiwa Securities Group's largest Q4 2018 buy was SITE Centers: 16,021,815 shares worth $138M.
  • Daiwa Securities Group added most to American Tower in Q4 2018, an estimated $128M increase.
  • Daiwa Securities Group's biggest Q4 2018 reduction was Crown Castle, cutting an estimated $211M.
  • Daiwa Securities Group fully exited Steris in Q4 2018, selling an estimated $11.9M.
  • Daiwa Securities Group's ten largest holdings make up 33% of its $10.4B portfolio in Q4 2018.
  • Daiwa Securities Group opened 73 new positions and closed 97 in Q4 2018.
  • Daiwa Securities Group's portfolio value fell 13% quarter-over-quarter to $10.4B.

Based on Daiwa Securities Group's 13F filing for Q4 2018, filed 5 Feb 2019.